Feed/Companies/Grow Therapy

Grow Therapy

As of 14 Oct 2026, Grow Therapy has raised $150M across 1 verified round on record; latest: $150 million Series D led by Goldman Sachs Alternatives and TCV, announced 3 Mar 2026.

BUILT ON

Visit site

They offer mental health therapy services, including talk therapy and medication management, primarily targeting individuals seeking mental health support.

growtherapy.comLinkedIn

LATEST ROUND

Series D

$150M · 2026-03-03

RAISED ON RECORD · USD

$150M

across 1 verified round

INVESTORS

2 leads

SOURCES

from 1 publisher

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series D

$150M · 2026-03-03

[ HISTORY ]

led by Goldman Sachs Alternatives, TCV

Round	Amount	Announced	Lead	Buzz
Series D [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$150M	2026-03-03	Goldman Sachs Alternatives, TCV	No recent discussion
1 source [ VERIFIED · CORRECTED ] read against 1 source Lead added Goldman Sachs Alternatives · prnewswire.com The source names Plus Capital only among Grow Therapy's key investors, not as an investor in this round.

Grow Therapy

Rounds

Company

Rounds

Sources

Profile

Investors

Grow Therapy

Rounds

Profile

Sources

Series D$150M2026-03-031 source

Investors

Series D$150M2026-03-037 investors